The Association Between Vitamin D Level with IgA Plasma Level in Pregnant COVID-19 Patients
Abstract
Background: Coronavirus disease (COVID-19) has emerged as a harmful pandemic this century, brought on by severe acute respiratory illness coronavirus-2. An ecological study has shown that greater levels of vitamin D intake are inversely linked with the occurrence and/or death of COVID-19 in communities with a genetic predisposition towards low micronutrient levels. IgA, the predominant immunoglobulin of the respiratory system, is the main entry point for a variety of bacteria..
Aim: The IgA plasma levels of COVID-19 pregnant patients were examined to see if there was a relationship with their vitamin D levels..
Patients and methods: At Bint -Alhuda teaching hospital, Obstetrics and Gynecology department and a private obstetrical clinic carried out a case control study from January to December 2022 to compare the levels of vitamin D and IgA in pregnant women with COVID-19 to those who did not have the virus. The study's objective was accomplished using a sample of 179 patients split into two groups. Group B comprised 77 healthy pregnant women who served as the control group, while Group A comprised 102 pregnant women who had COVID-19 at any point throughout their pregnancy...
Results: The mean of trimester, parity, family history of COVID-19, presence of COVID-19, and immunization history were found to differ significantly (p<0.05) in this study. When compared to the control group, pregnant women with a COVID-19 infection were shown to have significantly reduced levels of vitamin D and IgA (P=0.0001). It's interesting to note that, independent of group, a small but statistically significant positive association was found between both Vit D levels and IgA levels. Further investigation revealed a correlation between an IgA level above >2.1 and a case's sensitivity of 72%, specificity of 63%, and accuracy of 68%..
Conclusion: COVID-19 infection among pregnant women was found to result in lower levels of Vitamin D and IgA. Both groups showed significant correlation between levels of Vit D and IgA.
References
2. Center for Systems Science and Engineering (CSSE) at Johns Hopkins University. Coronavirus COVID-19 global cases by Johns Hopkins CSSE. [cited 2021/7/17]; Available from: https://coronavirus.jhu.edu/map.html.
3. WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. Available at https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. February 11, 2020; Accessed: July 13, 2021.
4. Gorbalenya AE. Severe acute respiratory syndrome-related coronavirus – The species and its viruses, a statement of the Coronavirus Study Group. Available at https://doi.org/10.1101/2020.02.07.937862. February 11, 2020; Accessed: Accessed: July 13, 2021.
5. Dubey P, Reddy SY, Manuel S, Dwivedi AK. Maternal and neonatal characteristics and outcomes among COVID-19 infected women: an updated systematic review and meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2020 Sep 1;252:490-501.
6. Abdelazim IA, AbuFaza M, Al-Munaifi S. COVID-19 positive woman presented with preterm labor: case report. Gynecology Obstetrics & Reproductive Medicine. 2021 Dec 15;27(3):294-6.
7. Hua J, Shaw R. Corona virus (Covid-19)“infodemic” and emerging issues through a data lens: The case of china. International journal of environmental research and public health. 2020 Jan;17(7):2309.
8. Cascella M , Rajnik M , Cuomo A , et al., Features, evaluation and treatment coronavirus (COVID-19). Stat pearls [internet] . Treasure Island (FL): Stat Pearls Publishing, Jan 2021.
9. Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Mar 17.
10. Van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. N Engl J Med. 2020 Mar 17.
11. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, Franco JL, Holland SM, Klein C, Morio T, Ochs HD. Human inborn errors of immunity: 2019 update on the classification from the International Union of Immunological Societies Expert Committee. Journal of clinical immunology. 2020 Jan;40(1):24-64.
12. Burgess S, Ponsford MJ, Gill D. Are we underestimating seroprevalence of SARS-CoV-2?. Bmj. 2020 Sep 3;370.
13. Ejemel M, Li Q, Hou S, Schiller ZA, Tree JA, Wallace A, Amcheslavsky A, Kurt Yilmaz N, Buttigieg KR, Elmore MJ, Godwin K. A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction. Nature communications. 2020 Aug 21;11(1):1-9.
14. Saito S, Sano K, Suzuki T, Ainai A, Taga Y, Ueno T, Tabata K, Saito K, Wada Y, Ohara Y, Takeyama H. IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody. PLoS Pathogens. 2019 Jan 3;15(1):e1007427.
15. Terauchi Y, Sano K, Ainai A, Saito S, Taga Y, Ogawa-Goto K, Tamura SI, Odagiri T, Tashiro M, Fujieda M, Suzuki T. IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration. Human vaccines & immunotherapeutics. 2018 Jun 3;14(6):1351-61.
16. Ashtary-Larky D, Kheirollah A, Bagheri R, Ghaffari MA, Mard SA, Hashemi SJ, Mir I, Wong A. A single injection of vitamin D3 improves insulin sensitivity and β-cell function but not muscle damage or the inflammatory and cardiovascular responses to an acute bout of resistance exercise in vitamin D-deficient resistance-trained males. British Journal of Nutrition. 2020 Feb;123(4):394-401.
17. Martineau AR, Jolliffe DA, Hooper RL, Greenberg L, Aloia JF, Bergman P, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. bmj. 2017 Feb 15;356.
18. McCartney DM, Byrne DG. Optimisation of vitamin D status for enhanced immuno-protection against Covid-19. Ir Med J. 2020 Apr 3;113(4):58.
19. Merzon E, Tworowski D, Gorohovski A, Vinker S, Golan Cohen A, Green I, Frenkel‐Morgenstern M. Low plasma 25 (OH) vitamin D level is associated with increased risk of COVID‐19 infection: an Israeli population‐based study. The FEBS journal. 2020 Sep;287(17):3693-702.
20. Ilie PC, Stefanescu S, Smith L. The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging clinical and experimental research. 2020 Jul;32(7):1195-8.
21. Chang TS, Ding Y, Freund MK, Johnson R, Schwarz T, Yabu JM, Hazlett C, Chiang JN, Wulf A, Geschwind DH, Butte MJ. Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health System. MedRxiv. 2020 Jul 4.
22. D’Avolio A, Avataneo V, Manca A, Cusato J, De Nicolò A, Lucchini R, Keller F, Cantù M.
23. Hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2. Nutrients. 2020 May;12(5):1359.
24. Petrelli F, Luciani A, Perego G, Dognini G, Colombelli PL, Ghidini A. Therapeutic and prognostic role of vitamin D for COVID-19 infection: A systematic review and meta-analysis of 43 observational studies. The Journal of steroid biochemistry and molecular biology. 2021 Jul 1;211:105883.
25. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, Bhattoa HP. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 2020 Apr;12(4):988.
26. Jude EB, Ling SF, Allcock R, Yeap BX, Pappachan JM. Vitamin D deficiency is associated with higher hospitalization risk from COVID-19: a retrospective case-control study. The Journal of Clinical Endocrinology & Metabolism. 2021 Nov;106(11):e4708-15.
27. Hernández JL, Nan D, Fernandez-Ayala M, García-Unzueta M, Hernández-Hernández MA, López-Hoyos M, et al. Vitamin D status in hospitalized patients with SARS-CoV-2 infection. The JThe Journal of Clinical Endocrinology & Metabolism. 2021 Mar;106(3):e1343-53.
28. Bahat PY, Talmac MA, Bestel A, Selcuki NF, Aydın Z, Polat İ. Micronutrients in COVID-19 positive pregnancies. Cureus. 2020 Sep 23;12(9).
29. Elham AS, Azam K, Azam J, Mostafa L, Nasrin B, Marzieh N. Serum vitamin D, calcium, and zinc levels in patients with COVID-19. Clinical Nutrition ESPEN. 2021 Jun 1;43:276-82.
30. Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J. Association of vitamin D status and other clinical characteristics with COVID-19 test results. JAMA network open. 2020 Sep 1;3(9): e2019722-.
31. Pérez-López FR, Fernández-Alonso AM, Chedraui P, Moreno LA; Spanish Vitamin D and Women’s Health Research Group: Hypovitaminosis D during pregnancy: are we ready to recommend vitamin D supplementation?. Gynecol Endocrinol. 2012, 28:856-858.
32. Ilie PC, Stefanescu S, Smith L: The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clin Exp Res. 2020, 32:1195-1198.
33. Chao YX, Rötzschke O, Tan EK. The role of IgA in COVID-19. Brain, Behavior, and Immunity. 2020 Jul;87:182.
34. Çölkesen F, Kandemir B, Arslan Ş, Çölkesen F, Yıldız E, Korkmaz C, Vatansev H, Evcen R, Aykan FS, Kılınç M, Aytekin G. Relationship between selective IgA deficiency and COVID-19 prognosis. Japanese Journal of Infectious Diseases. 2022 May 31;75(3):228-33.
